Open AccessThis article is
- freely available
Transparency of Reporting in Molecular Diagnostics
Postgraduate Medical Institute, Anglia Ruskin University, Chelmsford CM1 1SQ, UK
Received: 3 July 2013; in revised form: 23 July 2013 / Accepted: 23 July 2013 / Published: 30 July 2013
Abstract: The major advances made over the past few years in molecular and cell biology are providing a progressively more detailed understanding of the molecular pathways that control normal processes and become dysregulated in disease . This has resulted in the documentation of numerous genetic, epigenetic, transcriptomic, proteomic and metabolomic biomarkers that promise earlier disease detection, more accurate patient stratification and better prognosis [2–5]. Furthermore, molecular fingerprinting of diseases can be predictive of drug response and so assist with specific targeting of drugs against disease-associated molecules and function . [...]
Citations to this Article
Cite This Article
MDPI and ACS Style
Bustin, S. Transparency of Reporting in Molecular Diagnostics. Int. J. Mol. Sci. 2013, 14, 15878-15884.
Bustin S. Transparency of Reporting in Molecular Diagnostics. International Journal of Molecular Sciences. 2013; 14(8):15878-15884.
Bustin, Stephen. 2013. "Transparency of Reporting in Molecular Diagnostics." Int. J. Mol. Sci. 14, no. 8: 15878-15884.